Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The tspA/tpsB locus evolved in the hyperinvasive lineages with the appearance of repeated N-terminal-truncated tpsA genes ( tpsC cassettes) and Immunity Open Reading Frames (IORFs), which are absent in cc53 (Mullally et al., 2021)
Product Features Available in 5mg and 10mg vial options Selective GHSR-1a receptor agonist Lyophilised powder in sterile, sealed vial High purity verified through third-party analytical testing Tamper-evident, batch-labelled packaging Suitable for laboratory and in-vitro research applications Research Applications Ipamorelin is commonly utilised in laboratory environments involving: Growth hormone secretagogue receptor (GHSR-1a) signalling Peptidereceptor interaction studies cAMP/PKA and PLC/IP3/Ca pathway modelling Structureactivity relationship investigations Controlled endocrine and signalling pathway research Molecular biology and receptor pharmacology studies Its selective receptor activity profile has made Ipamorelin a valuable compound within controlled peptide-signalling and receptor pathway investigations
Medicaid coverage for Ozempic is generally reserved for FDA-approved indications
Contact our Export Team for: Volume discounts (MOQ: 50 units)
T2DM: type 2 diabetes mellitus Recent research has revealed that TMAO may be a risk factor for the onset and progression of atherosclerosis, along with food and gut microbiota both of which may play a role in the development of cardiovascular disease, including atherosclerosis [68, 69]
For the broader picture of which peptides already have FDA approval, see our FDA Approved Peptides List 2026
